Coverage
-
April 10, 2025
A creditor trust created under Amyris' Chapter 11 plan has sued the biotechnology company's former CEO in Delaware bankruptcy court, accusing him of abandoning his fiduciary duties by entering into a product licensing deal that locked in low prices for its cosmetics ingredients and contributed to the firm's insolvency.
22 other articles on this case.
View all »